/

Will Levis Remains Titans' Starter Despite Shoulder Injury Concerns

1 hour ago

Will Levis Remains Titans' Starter Despite Shoulder Injury Concerns

Generated image for illustrative purposes:

7 Highlights

Levis remains Titans' QB1 despite a shoulder injury.
MRI to assess the severity of Levis' injury after his dive.
- Callahan prioritizes Levis' health above all.
- Rudolph stepped in, helping secure a win over the Dolphins.
- Rudolph completed 9 of 17 passes for 85 yards.
- Titans scored 31, their highest in over 1,000 days.
- Bye week allows Levis time to recover before Colts game.

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Related Articles

Scientists Reveal How Ancient Egyptian Mummy Was Coffin Sealed 'With No Opening'

Generated image for illustrative purposes:

Scientists Reveal How Ancient Egyptian Mummy Was Coffin Sealed 'With No Opening'

9 seconds ago

Scans reveal secrets of mummy Chenet-aa in sealed coffin.
- Field Museum uses CT scans to study 3,000-year-old mummy.
- Chenet-aa lived during Egypt's 22nd Dynasty, showing high status.
- Mummy embalmed in Egypt's Third Intermediate Period found intact.
- Ancient humidified cartonnage sealed Chenet-aa in her coffin.
- Six wax statues, sons of Horus, found inside her coffin.
- Researchers aim to view mummies as people, not just artifacts.

49ers Suffer Late Defeat to Seahawks Despite Strong Showing from Jennings

Generated image for illustrative purposes:

49ers Suffer Late Defeat to Seahawks Despite Strong Showing from Jennings

3 minutes ago

49ers lost 20-17 to Seahawks, dropping to a 5-5 record this season.
- Geno Smith led Seattle's winning 80-yard drive in the game's final moments.
- Jauan Jennings impressed with 91 yards and a crucial touchdown for the 49ers.
- Brock Purdy threw for 159 yards, one touchdown, and an interception.
- 49ers struggled with penalties and closing out late in the game.
- Fred Warner voiced frustration over the team's late defensive slip.
- 49ers tie for second in NFC West, impacting playoff prospects for both teams.

I'm A Celeb: Viewers React to Ad Breaks and First Episode Antics

Generated image for illustrative purposes:

I'm A Celeb: Viewers React to Ad Breaks and First Episode Antics

4 minutes ago

I'm A Celebrity returns with record-breaking lineup on ITV.
- Viewers complain about excessive ads in 100-minute episode.
- Coleen Rooney jokes about Wagatha Christie trial on first day.
- Danny Jones encounters a snake during jungle trial.
- Ant and Dec deliver humor with jabs at Rooney's famous trial.
- Celebrities, including Tulisa and GK Barry, skydive into jungle.
- Season entertains with mix of tension and humor despite complaints.

I'm A Celebrity 2024 Launch: Ant and Dec Tease Coleen Rooney

Generated image for illustrative purposes:

I'm A Celebrity 2024 Launch: Ant and Dec Tease Coleen Rooney

4 minutes ago

Coleen Rooney enters 'I'm A Celebrity' with £1.5M record deal.
- Rooney leaves Wagatha scandal behind in jungle adventure.
- GK Barry impresses with reaction to Barry McGuigan's intro.
- Ant and Dec humorously reference past and present celeb events.
- 2024 'I'm A Celebrity' promises diverse, engaging challenges.
- ITV aims for high engagement with varied celebrity cast.
- Lineup includes Oti Mabuse, McFly's Danny Jones, and more.

Janus Henderson Debuts in Europe with New Collateralized Loan ETF

Generated image for illustrative purposes:

Janus Henderson Debuts in Europe with New Collateralized Loan ETF

8 minutes ago

Janus Henderson to launch first CLO ETF in Europe, registered in Luxembourg.
- Janus Henderson sees $12.6bn assets in US, highlighting CLO's global surge.
- Bryan Armour notes $11.5bn net inflows into Janus Henderson's US ETF.
- CLO ETF interest dramatically rose from $500mn to $18bn in three years.
- BlackRock and VanEck plan CLO ETFs, showing European market trend.
- Fair Oaks Capital launched Europe's first CLO ETF in September.
- Janus Henderson strengthens European presence with Tabula acquisition.

Log in to continue reading

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy. You also agree to receive our newsletters, you can opt-out any time.

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.